Skip to content

Invivyd, Inc.

IVVD· NasdaqCore metricsCIK 1832038

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -5.81%
Market cap
$166.38M
295.63M shares
Filings
452
$15.45M
Q3 2026+110.5% FY25 yoy
-$33.47M
Q3 2026N/M FY25 yoy
-$34.68M
Q3 2026N/M FY25 yoy
-$118.65M
Q3 2026derivedN/M FY25 yoy
-$0.10
Q3 2026N/M FY25 yoy
$126.40M
Q3 2026+226.9% FY25 yoy
$166.38M
—
2.7×
1.1×
-80.60%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.562865.99%$1.0922past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$53.43MFY 2025
$53.43M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$53,426,000reported
FY 20242024-12-31$25,384,000reported
FY 20232023-12-31$0reported

Capital returns

Dividends and buybacks · FY2021 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$0.00$0.00—119.96M sh+0.6%—
FY2023—$1.00K$1.00K—119.22M sh+9.2%—
FY2022—$4.00K$4.00K—109.19M sh−0.4%—
FY2021—$0.00$0.00—109.68M sh+1,860.9%—

Biological products, except diagnostic substances

Invivyd, Inc. is the 41st largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Invivyd, Inc. · CIK 1832038 · Engraved from SEC EDGAR